Piperacillin Tazobactam Prices, Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data Report 2025 Edition
Piperacillin Tazobactam Price Trend, Index and Forecast
Track the latest insights on piperacillin tazobactam price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Piperacillin Tazobactam Prices Outlook Q2 2025
- Spain: US$ 913800/MT
- Italy: US$ 897680/MT
- France: US$ 831930/MT
- Austria: US$ 868120/MT
- USA: US$ 761690/MT
Piperacillin Tazobactam Price Chart
Get real-time access to monthly/quaterly/yearly prices, Request Sample
During the second quarter of 2025, the piperacillin tazobactam prices in Spain reached 913800 USD/MT in June. As per the piperacillin tazobactam price chart, the rising incidence of serious bacterial infections and drug-resistant pathogens sustained steady demand from hospitals and healthcare institutions in Spain. This consistent consumption kept pressure on pricing. Besides, market saturation from established suppliers, combined with supply bottlenecks, further caused fluctuations in prices.
During the second quarter of 2025, the piperacillin tazobactam prices in Italy reached 897680 USD/MT in June. Regulatory compliance under EU regulations increased inspection and certification expenses. Currency fluctuations also played a role in shaping import dynamics, while inland logistics and warehousing added distribution-related costs. Healthcare budget constraints placed some downward pressure, but rising treatment demand in infectious disease wards balanced the pricing trend.
During the second quarter of 2025, piperacillin tazobactam prices in France reached 831930 USD/MT in June. Currency movements within the eurozone affected contract competitiveness, as most imports were dollar-denominated. Domestic logistics, including cold chain distribution, added to final costs. Compliance with EU quality standards and hospital audits further contributed to overall expenses, sustaining prices at elevated levels.
During the second quarter of 2025, the piperacillin tazobactam prices in Austria reached 868120 USD/MT in June. Freight charges, customs protocols, and regional distribution costs were central in shaping the price environment. Since Austria relies on imports for pharmaceutical supply, fluctuations in international shipping rates directly impacted landed costs. Customs procedures within the EU added administrative expenses and time delays, while regional distribution from central logistics hubs to hospitals and pharmacies increased domestic transport expenses, particularly with rising fuel and labor costs in the logistics sector.
During the second quarter of 2025, the piperacillin tazobactam prices in the USA reached 761690 USD/MT in June. Demand was robust, particularly in hospitals managing multidrug-resistant infections. Domestic logistics, including long-haul trucking and storage in compliance with FDA requirements, raised distribution expenses. Currency changes in US dollar contracts influenced volatility, but freight fluctuations added pressure. Increased compliance expenses due to FDA inspections further shaped pricing, though large-scale procurement contracts by hospital networks helped negotiate partial cost offsets.
Piperacillin Tazobactam Prices Outlook Q2 2023
- China: US$ 109755/MT
- Germany: US$ 423060/MT
In June 2023, the price of piperacillin tazobactam in China reached 109755 USD/MT.
In Germany, the piperacillin tazobactam price reached 423060 USD/MT in June 2023.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the piperacillin tazobactam prices.
Global Piperacillin Tazobactam Price Trend
The report offers a holistic view of the global piperacillin tazobactam pricing trends in the form of piperacillin tazobactam price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price levels but also provides insights into historical price of piperacillin tazobactam, enabling stakeholders to understand past fluctuations and their underlying causes. The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed piperacillin tazobactam demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Europe Piperacillin Tazobactam Price Trend
Q2 2025:
European prices were shaped by consistent healthcare sector demand across major markets including Spain, Italy, France, and Germany. Besides, port handling charges, customs clearance, and international freight rates influenced landed costs. Dollar-denominated contracts exposed procurement to currency movements against the euro. EU regulatory compliance for pharmaceuticals, including GMP and pharmacovigilance requirements, added certification costs. Domestic logistics across multiple countries, with varying healthcare distribution networks, further raised overall expenses.
Q1 2023:
European piperacillin tazobactam prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.
This analysis can be extended to include detailed piperacillin tazobactam price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Piperacillin Tazobactam Price Trend
Q2 2025:
As per the piperacillin tazobactam price index, prices were primarily shaped by the United States market. Strong demand from hospitals treating resistant infections sustained procurement activity. Imports formed a significant portion of supply, making prices highly sensitive to shipping charges and port logistics. Domestic distribution costs, including trucking and FDA-compliant warehousing, added further expense. While the US dollar provided stability in global contracts, fluctuations in freight costs created pricing volatility. Compliance with FDA regulatory standards contributed to certification and inspection costs across the supply chain.
Q1 2023:
The analysis of piperacillin tazobactam prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.
Specific piperacillin tazobactam historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Piperacillin Tazobactam Price Trend
Q2 2025:
The report explores the piperacillin tazobactam trends and piperacillin tazobactam price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
Q1 2023:
The report explores the piperacillin tazobactam pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on piperacillin tazobactam prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Piperacillin Tazobactam Price Trend
Q2 2025:
In Asia Pacific, prices were driven by API production in key markets like China and India, which dominate global supply. Seasonal variations in raw material availability and domestic regulatory checks influenced cost structures. Export volumes influenced domestic availability in producing countries. Inland logistics from manufacturing sites to ports, along with shipping charges, shaped overall landed costs. Currency fluctuations against the US dollar influenced competitiveness of exports, while compliance with international quality certifications added additional overheads.
Q1 2023:
The piperacillin tazobactam pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.
This piperacillin tazobactam price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Piperacillin Tazobactam Price Trend
Q2 2025:
Latin America's piperacillin tazobactam market is predominantly influenced by its rich natural reserves, particularly in countries like Chile and Brazil. However, political instability and inconsistent regulatory frameworks can lead to significant volatility in piperacillin tazobactam prices. Infrastructure challenges and logistical inefficiencies often impact the supply chain, affecting the region's ability to meet international demand consistently. Moreover, the piperacillin tazobactam price index, economic fluctuations, and currency devaluation are critical factors that need to be considered when analyzing piperacillin tazobactam pricing trends in this region.
Q1 2023:
The analysis of piperacillin tazobactam prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Piperacillin Tazobactam Price Trend, Market Analysis, and News
IMARC's latest publication, “Piperacillin Tazobactam Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the piperacillin tazobactam market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of piperacillin tazobactam at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed piperacillin tazobactam prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting piperacillin tazobactam pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Piperacillin Tazobactam Industry Analysis
The global piperacillin tazobactam market size reached USD 141.28 Million in 2024. By 2033, IMARC Group expects the market to reach USD 187.59 Million, at a projected CAGR of 3.04% during 2025-2033.
- According to the report of the National Library of Medicine 2023, 33% of annual deaths are due to infectious diseases, accounting for 52 million deaths worldwide. There is a rise in the need for effective broad-spectrum antibiotics like piperacillin tazobactam to treat these infections. Its ability to fight against pathogens makes it highly valuable in healthcare facilities.
- People are aware about the harmful impact of infectious diseases, and so they are frequently visiting hospitals to get apt treatment. Improvements in diagnostics techniques are also resulting in accurate identification of these diseases, thus driving the demand for piperacillin tazobactam.
- Emerging advanced healthcare facilities further increase the demand for piperacillin tazobactam. This brings in return improvement regarding access to the recent treatments in medicine and educated healthcare professionals. Enhanced healthcare infrastructure also helps in treating and preventing diseases across the globe.
- The market share showed an upward trajectory on account of several R&D projects going on around the world. These R&D projects are helping in developing advanced and efficient piperacillin tazobactam.
- Piperacillin tazobactam is increasingly popular as governing agencies of several countries are undertaking initiatives to combat antimicrobial resistance. This, in turn, is facilitating the approvals for the production of piperacillin tazobactam. The market share is also expanding because of the increasing geriatric population worldwide, which is more susceptible to infectious diseases.
- The piperacillin tazobactam market is being further reinforced by mergers and acquisitions (M&A), partnerships, and collaborations between healthcare providers, pharmaceutical companies, and research institutions. These can also be viewed as their strategies to enhance distribution channels and expand their market reach.
- There is a global need to ensure the health of livestock and pets against severe infectious diseases. Piperacillin tazobactam plays a crucial role in manufacturing veterinary medicines to prevent infectious diseases among these animals. The IMARC Group’s report claims that the global veterinary medicine market is projected to reach US$ 59.1 Billion by 2032.
Piperacillin Tazobactam News
The report covers the latest developments, updates, and trends impacting the global piperacillin tazobactam industry, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in piperacillin tazobactam production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the piperacillin tazobactam price trend.
Latest developments in the Silica Sand industry:
- In 2023, Baxter International Inc. launched zosyn in the US, which is a piperacillin tazobactam injection to treat multiple infections.
- In 2024, Orchid Pharma announced that it has received the European Medicines Agency’s (EMA) recommendation for marketing authorization of antibiotic named Exblifeb, which incorporates Enmetazobactam. It is designed to combat the global challenge of anti-microbial resistance (AMR).
Product Description
Piperacillin tazobactam is a combination antibiotic of piperacillin and tazobactam, which is a penicillin antibiotic and beta-lactamase inhibitor respectively. Gram-positive and gram-negative bacteria can be easily prevented through this drug. This combination of drugs is highly effective against several infectious diseases, which is otherwise untreatable.
Its excellent antibacterial activity makes it highly effective against healthcare-acquired infections (HAIs). These infections are very dangerous as they are caused by multi-drug resistant organisms, thereby highlighting the importance of piperacillin tazobactam. Healthcare professionals are also realizing the importance of these drugs owing to their ability in treating complicated UTIs, soft tissue infections, and multi-abdominal infections.
Its versatility can be further explained by its utilization in treating a particular condition, known as febrile neutropenia, experienced by cancer patients undergoing chemotherapy.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Piperacillin Tazobactam |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Piperacillin Tazobactam Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of piperacillin tazobactam pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting piperacillin tazobactam price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The piperacillin tazobactam price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.